Palos Heights, Illinois Clinical Trials

A listing of Palos Heights, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 92 clinical trials
Phase III Study Assessing the Efficacy Safety and Immunogenicity of SOK583A1 Versus Eylea in Patients With Neovascular Age-related Macular Degeneration

Purpose and rationale: To demonstrate similar efficacy, safety and immunogenicity of SOK583A1 and Eylea EU as per Eylea approved treatment regimen in patients with nAMD. The primary clinical question of interest is: Does SOK583A1 have similar efficacy as Eylea EU in terms of mean change in BCVA score in participants …

Sandoz Investigational Site
 (4.3 away) Contact site
  • 0 views
  • 17 Jul, 2021
  • +37 other locations
A Phase 3 Multi-Center Randomized Double-Blind Placebo-Controlled Study of Fostamatinib Disodium in the Treatment of wAIHA

The primary objective of this study is to assess the efficacy of fostamatinib in subjects with warm antibody autoimmune hemolytic anemia (wAIHA).

Affiliated Oncologists
 (2.8 away) Contact site
  • 113 views
  • 31 Jul, 2021
  • +125 other locations
COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis

A multicenter, adaptive, randomized platform trial evaluating the efficacy and safety of antithrombotic strategies in patients with COVID-19 following hospital discharge

OSF Little Company of Mary
 (6.2 away) Contact site
  • 0 views
  • 01 Aug, 2021
  • +74 other locations
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

This phase III trial studies how well vitamin D3 given with standard chemotherapy and bevacizumab works in treating patients with colorectal cancer that has spread to other parts of the body. Vitamin D3 helps the body use calcium and phosphorus to make strong bones and teeth. Drugs used in chemotherapy, …

cancer treatment
neutrophil count
vitamin d
monoclonal antibodies
open biopsy
Loyola Center for Cancer Care and Research
 (3.9 away) Contact site
  • 65 views
  • 27 Jul, 2021
  • +978 other locations
A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer

The main purpose of this study is to measure how well abemaciclib works in participants with early breast cancer who are taking hormone therapy after surgery. Participants must have breast cancer that is hormone receptor positive (HR+) and human epidermal receptor 2 positive (HER2+). Your participation could last up to …

invasive breast cancer
HER2
pertuzumab
hormone therapy
trastuzumab
Affiliated Oncologists, LLC
 (2.8 away) Contact site
  • 0 views
  • 28 Jul, 2021
  • +535 other locations
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss

This is a study of tirzepatide in participants with obesity or overweight. The main purpose is to learn more about how tirzepatide maintains body weight loss. The study has two phases: a lead-in phase in which all participants take tirzepatide and a treatment phase in which participants will either continue …

body mass index
hypertension
dyslipidemia
cardiovascular disease
Healthcare Research Network - Chicago
 (10.0 away) Contact site
  • 9 views
  • 30 Jul, 2021
  • +76 other locations
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer the CompassHER2 RD Trial

This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted …

University of Chicago Medicine-Orland Park
 (3.9 away) Contact site
  • 0 views
  • 26 Jul, 2021
  • +762 other locations
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS) is a group of disorders that gradually affect the ability of a person's bone marrow (semi-liquid tissue present in many bones like backbones) to produce normal blood cells. Some people with MDS have a risk of the disease progressing to acute myeloid leukemia (AML), and a risk …

remission
azacitidine
anemia
myeloid leukemia
leukemia
Ingalls Memorial Hosp /ID# 220844
 (8.0 away) Contact site
  • 27 views
  • 01 Aug, 2021
  • +322 other locations
A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Patients With Metastatic Colorectal Cancer

This is a global, randomized, double-blind, placebo-controlled, multicenter phase 3 clinical trial to compare the efficacy and safety of fruquintinib plus best supportive care (BSC) versus placebo plus BSC in patients with refractory metastatic colorectal cancer (mCRC). 687 subjects will be randomized to one of the following treatment arms in …

tipiracil
vegf
fluoropyrimidine
adenocarcinoma
cancer
Affiliated Oncologists
 (2.8 away) Contact site
  • 0 views
  • 17 Jul, 2021
  • +145 other locations
ACTIV-2: A Study for Outpatients With COVID-19

Drug studies often look at the effect one or two drugs have on a medical condition, and involve one company. There is currently an urgent need for one study to efficiently test multiple drugs from more than one company, in people who have tested positive for COVID-19 but who do …

pharyngitis
fever
ageusia
sore throat
SARS
Metro Infectious Disease Consultants (Site 1106), 901 McClintock Dr., Ste. 201
 (9.0 away) Contact site
  • 104 views
  • 30 Jul, 2021
  • +238 other locations